Member Info for uxm484

Possible take over bid. Deal being struck. If was delay they would of told us. Something big happening......

Positive signs.

The test is a success but how good. My favourite tweet on 23rd Feb that gives a hint is below.

We’ve not only sequenced “its” RNA (it doesn’t have DNA, this virus), but we’ve sequenced many thousands of them.

This means if they can identify the RNA of the virus they should be able to pick up the virus. Many thousands is confirming to me they can pick up variants and this was posted on the 23rd. Carl previously stated that his test should pick up the variants. If the test was a failure I highly doubt the statement above would apply. Got a feeling we may get 100% and our test might be the best just a feeling. We should feel confident....

Reward far outweighs risk here. An excellent entry point.

A link for another one of mine. Slightly longer term but great one to on the look out for. https://twitter.com/hashtag/n4p?f=live

I would expect the RNS tomorrow. They released an RNS the last day of last month to let us know and again speeding ticket last week confirmed it was still expected that at the end of Feb they would know the results. This time the samples have all been tested so we would expect and RNS. If not they will probably let us know...

Hoping for £3 close tomorrow bring it on...

How many times do you guys wanna lose money on this stock. Complete madness.

As previously announced the maximum production capacity of the machine was expected to be around 5 million masks per month, based on the machine being operated for 24 hours per day and 7 days per week. The current production rate is significantly below these levels and the commissioning process has identified a number of issues that need to be resolved over the coming weeks in order to improve the machine's productive capacity. The Company is in discussions regarding the appointment of an independent adviser to assist P2F with the development of the production facility, including building up the production team to operate a single shift and enabling a gradual increase from the current limited level of production to commence, and to undertake a review of the best routes for exploiting the anti-viral mask technology. This is expected to be confirmed in the near future. The Company will provide further updates as it progresses these goals in due course.

Should be below 1p. The RNS released last week made it clear it was not where it was. Hence why it will drop...

They just said last week as well when the speeding ticket was issued end of Feb. Once results are known no reason to release to the market immediately.

Decent chance of mid after today but most likely tomorrow. If it gets released today then hopefully everyone has cash ready as it will rocket within seconds and you will just have to try to catch the rocket.....

Not really. Only if it is a complete failure which we know is not the case from Carl's twitter. Worst case slight delay with potential factored in therefore 10-20 per cent drop. Upside is few 100% and probability of success appears to be greater than failure....

Cleary a large buy order going through.... Exciting times.

Spread the rocket....Would be good for everyone to get in before the big RNS....

Could be either day. I think it could be a tactical move here. If no RNS tomorrow then that leaves one day. Most likely everyone in AIM tries to jump in tomorrow if they release the RNS on the last possible day which if Friday. Therefore with little stock we end up with a very significant rise tomorrow. If no RNS tomorrow then tomorrow is the day to promote.

3 test per pupil a big task. Therefore we need a quick 5 min test.

This is when Braveheart come to the rescue. A contract is a given upon successful results.

The clinical trails in this case are more of a validation process. They would of done detailed studies in the lab which confirmed that the test works. This is standard procedure. What is not know is the % of accuracy unless it goes completely wrong but you would be 95% sure that it works to some extent.

Here are my notes........Current market cap only 37 millions. 37 Million share in issue. Should head to 370 p within a week upon successful results.

The US is a massive market. This is not only a one trick pony. Will also reduce NHS wait times for diseases like cancer by detecting limits of such diseases within minutes and will enable other viruses including different strains of the coronavirus to be detected.

Tweet yesterday by the professor stated people did not understand the value of the technology they have. No doubt heading to market cap 100 million plus.

The Paraytec and University of Sheffield team will use these samples to set the test operational parameters so that it attains or exceeds the recommended guidelines for upper limits on false positive and negative tests set by the Medical Health Regulatory Authority. Results from this phase of clinical testing are now expected by the end of February.

To minimise the effects of this delay, Paraytec has brought forward scheduled work, using isolated lab-grown virus to optimise the operational sensitivity (sometimes called 'lower limit of detection') of our instrument for the detection of pre-symptomatic and early-stage symptomatic levels of virus. Paraytec's target is to detect less than 1000 virions per millilitre of sample, which would represent a market leading performance, if achieved. By re-arranging the workflows Paraytec does not believe that there will be any overall delay to the development programme.

It is already clear that current vaccines are not 100% effective and the infection risk is being compounded by the emergence of new strains of the COVID-19 virus. Braveheart has been advised that the Paraytec and University of Sheffield team believes there is, and will continue to be, a significant and ongoing demand for rapid tests for the early detection of the virus, to protect communities and the world's economy.

Looking forward to a great return when results are announced. Last chance to buy..........

Up we go. Do not panic as I said....

The price at the moment is irrelevant. It's all about the results. Don't forget Synairgen went from 30's and reaching 250 in a day.

Our value will be in the RNS but if you are out we will opening at a new juicy price. If RNS is bad which I doubt then we will be opening at a new price regardless of where we are. If we are holding on for the results then the current price is not that important therefore no reason to panic.

For me complete failure is ruled out based on Prof Smythe twitter account.

Next you look at risk/ reward. I think about 20 % chance of a delay but within that you will likely get significant positives in the RNS therefore even with that you may only see a 10-20% drop. But upside on good results we could hit 300p-500p within a week. Massive upside potential and limited risk. I think we are very undervalued and with a lack of shares I really think we could be the stock of the year if results are good.

Great price to buy into currently.....

Our tests targets other diseases and viruses and that would likely in the long run have far greater value than the coronovirus.

Also our test is less than 5 minutes and we have more clinical samples than Avatca and co therefore this will add great value when getting contracts.

Very likely they are negotiating a deal in the background. Takes bit of time to hold meetings but no doubt something big happening. I see some big announcement coming with the RNS.